The global RNA-Seq market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global RNA-Seq market is experiencing rapid growth due to advancements in sequencing technologies, decreasing costs, and increasing demand for personalized medicine and genomics research. This market holds immense potential for further development and innovation, making it a focal point for companies and researchers in the life sciences industry.
This report aims to provide a comprehensive presentation of the global market for RNA-Seq, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA-Seq.
Report Scope
The RNA-Seq market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNA-Seq market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA-Seq companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
BGI
PacBio
Genewiz
Macrogen
LabCorp
Roche
Qiagen
Eurofins
Novo Gene
Berry Genomics
LC Sciences
Canopy Biosciences
Macrogen
Hologic
Segment by Type
sRNA-Seq
targeted RNA-Seq
long-read RNA-Seq
Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA-Seq companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Seq Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 sRNA-Seq
1.2.3 targeted RNA-Seq
1.2.4 long-read RNA-Seq
1.3 Market by Application
1.3.1 Global RNA-Seq Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA-Seq Market Perspective (2019-2030)
2.2 RNA-Seq Growth Trends by Region
2.2.1 Global RNA-Seq Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNA-Seq Historic Market Size by Region (2019-2024)
2.2.3 RNA-Seq Forecasted Market Size by Region (2025-2030)
2.3 RNA-Seq Market Dynamics
2.3.1 RNA-Seq Industry Trends
2.3.2 RNA-Seq Market Drivers
2.3.3 RNA-Seq Market Challenges
2.3.4 RNA-Seq Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-Seq Players by Revenue
3.1.1 Global Top RNA-Seq Players by Revenue (2019-2024)
3.1.2 Global RNA-Seq Revenue Market Share by Players (2019-2024)
3.2 Global RNA-Seq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA-Seq Revenue
3.4 Global RNA-Seq Market Concentration Ratio
3.4.1 Global RNA-Seq Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Seq Revenue in 2023
3.5 RNA-Seq Key Players Head office and Area Served
3.6 Key Players RNA-Seq Product Solution and Service
3.7 Date of Enter into RNA-Seq Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Seq Breakdown Data by Type
4.1 Global RNA-Seq Historic Market Size by Type (2019-2024)
4.2 Global RNA-Seq Forecasted Market Size by Type (2025-2030)
5 RNA-Seq Breakdown Data by Application
5.1 Global RNA-Seq Historic Market Size by Application (2019-2024)
5.2 Global RNA-Seq Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNA-Seq Market Size (2019-2030)
6.2 North America RNA-Seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNA-Seq Market Size by Country (2019-2024)
6.4 North America RNA-Seq Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA-Seq Market Size (2019-2030)
7.2 Europe RNA-Seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNA-Seq Market Size by Country (2019-2024)
7.4 Europe RNA-Seq Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA-Seq Market Size (2019-2030)
8.2 Asia-Pacific RNA-Seq Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNA-Seq Market Size by Region (2019-2024)
8.4 Asia-Pacific RNA-Seq Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA-Seq Market Size (2019-2030)
9.2 Latin America RNA-Seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNA-Seq Market Size by Country (2019-2024)
9.4 Latin America RNA-Seq Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-Seq Market Size (2019-2030)
10.2 Middle East & Africa RNA-Seq Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNA-Seq Market Size by Country (2019-2024)
10.4 Middle East & Africa RNA-Seq Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific RNA-Seq Introduction
11.1.4 Thermo Fisher Scientific Revenue in RNA-Seq Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina RNA-Seq Introduction
11.2.4 Illumina Revenue in RNA-Seq Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 BGI
11.3.1 BGI Company Detail
11.3.2 BGI Business Overview
11.3.3 BGI RNA-Seq Introduction
11.3.4 BGI Revenue in RNA-Seq Business (2019-2024)
11.3.5 BGI Recent Development
11.4 PacBio
11.4.1 PacBio Company Detail
11.4.2 PacBio Business Overview
11.4.3 PacBio RNA-Seq Introduction
11.4.4 PacBio Revenue in RNA-Seq Business (2019-2024)
11.4.5 PacBio Recent Development
11.5 Genewiz
11.5.1 Genewiz Company Detail
11.5.2 Genewiz Business Overview
11.5.3 Genewiz RNA-Seq Introduction
11.5.4 Genewiz Revenue in RNA-Seq Business (2019-2024)
11.5.5 Genewiz Recent Development
11.6 Macrogen
11.6.1 Macrogen Company Detail
11.6.2 Macrogen Business Overview
11.6.3 Macrogen RNA-Seq Introduction
11.6.4 Macrogen Revenue in RNA-Seq Business (2019-2024)
11.6.5 Macrogen Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Detail
11.7.2 LabCorp Business Overview
11.7.3 LabCorp RNA-Seq Introduction
11.7.4 LabCorp Revenue in RNA-Seq Business (2019-2024)
11.7.5 LabCorp Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche RNA-Seq Introduction
11.8.4 Roche Revenue in RNA-Seq Business (2019-2024)
11.8.5 Roche Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Detail
11.9.2 Qiagen Business Overview
11.9.3 Qiagen RNA-Seq Introduction
11.9.4 Qiagen Revenue in RNA-Seq Business (2019-2024)
11.9.5 Qiagen Recent Development
11.10 Eurofins
11.10.1 Eurofins Company Detail
11.10.2 Eurofins Business Overview
11.10.3 Eurofins RNA-Seq Introduction
11.10.4 Eurofins Revenue in RNA-Seq Business (2019-2024)
11.10.5 Eurofins Recent Development
11.11 Novo Gene
11.11.1 Novo Gene Company Detail
11.11.2 Novo Gene Business Overview
11.11.3 Novo Gene RNA-Seq Introduction
11.11.4 Novo Gene Revenue in RNA-Seq Business (2019-2024)
11.11.5 Novo Gene Recent Development
11.12 Berry Genomics
11.12.1 Berry Genomics Company Detail
11.12.2 Berry Genomics Business Overview
11.12.3 Berry Genomics RNA-Seq Introduction
11.12.4 Berry Genomics Revenue in RNA-Seq Business (2019-2024)
11.12.5 Berry Genomics Recent Development
11.13 LC Sciences
11.13.1 LC Sciences Company Detail
11.13.2 LC Sciences Business Overview
11.13.3 LC Sciences RNA-Seq Introduction
11.13.4 LC Sciences Revenue in RNA-Seq Business (2019-2024)
11.13.5 LC Sciences Recent Development
11.14 Canopy Biosciences
11.14.1 Canopy Biosciences Company Detail
11.14.2 Canopy Biosciences Business Overview
11.14.3 Canopy Biosciences RNA-Seq Introduction
11.14.4 Canopy Biosciences Revenue in RNA-Seq Business (2019-2024)
11.14.5 Canopy Biosciences Recent Development
11.15 Macrogen
11.15.1 Macrogen Company Detail
11.15.2 Macrogen Business Overview
11.15.3 Macrogen RNA-Seq Introduction
11.15.4 Macrogen Revenue in RNA-Seq Business (2019-2024)
11.15.5 Macrogen Recent Development
11.16 Hologic
11.16.1 Hologic Company Detail
11.16.2 Hologic Business Overview
11.16.3 Hologic RNA-Seq Introduction
11.16.4 Hologic Revenue in RNA-Seq Business (2019-2024)
11.16.5 Hologic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
Illumina
BGI
PacBio
Genewiz
Macrogen
LabCorp
Roche
Qiagen
Eurofins
Novo Gene
Berry Genomics
LC Sciences
Canopy Biosciences
Macrogen
Hologic
听
听
*If Applicable.
